Health Care: Drugs

Prothena Corp PLC (PRTA: NASDAQ)

$53.8 -1.2 | -2.18%
02/23/17 - 02:53 PM ET
Company Profile
Price and Volume
Recent Price 55.00
52 Week High 68.18
52 Week Low 30.37
Avg. Daily Vol. (Mil) 0.32
Beta (3 year) 0.12
Share Related Items
Mkt Cap (Mil) 1,896.86
Shares Out (Mil) 34.49
Float (Mil) 23.20
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 11.10
Current Ratio 11.30
LT Debt/ Equity 0.10
Total Debt / Equity 0.10
Valuation Ratios
Price Earnings n.a.
Price/Sales 1.80K
Price/Book 4.73
Price/Cash Flow -14.20
Per Share Data
Earnings -4.66
Sales 0.03
Book Value 11.63
Cash Flow -3.87
Business Summary
Prothena Corp PLC is a biotechnology company. It discovers and develops novel antibodies for the potential treatment of a broad range of diseases that involve protein misfolding or cell adhesion.
General Information
Upper George's Street
Adelphi Plaza
Dublin, A96 T927
Industry : Drugs
Sector: Health Care
Employees: 66
CEO: Dr. Gene Kinney
Short Interest
Current Month (Mil) 6.21
Previous Month (Mil) 5.90
Short Interest Ratio (Days) 21.60
Management Effectiveness
Return on Equity n.a.
Return on Assets -28.20
Return on Investments -30.70
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter